Related articles:
Infliximab
Etanercept
Abbott Laboratories
Psoriasis
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
Tumor necrosis factor-alpha
Key terms:
abbott
adalimumab
humira
tnf
mg
basf
antibody
ard
pen
bmj
disease
adults
knoll
alone
trial
treatment
approved
infections
patients
infliximab
fatal
royalty
marketed
clinical
etanercept
rheumatoid arthritis
psoriasis
syringe
indication
methotrexate
rare reports
moderate to severe
fully human
annual sales
been shown to reduce
adalimumab has been shown
manufacturing
immune system
united states
phage display
justice laddie
monoclonal antibody
psoriatic arthritis
launched humira
shown to reduce the signs
reduce the signs and symptoms
abbott laboratories
juvenile idiopathic arthritis
ankylosing spondylitis
cambridge antibody technology
Search external links cited by footnotes on Wikipedia page Adalimumab:
|
|